Effect of N-acetylcysteine on Rat Neuron Apoptosis and Neuropathic Pain

Feixiang WU,Yanhu GE,Xuerong MIAO,Xin LU,Xuewu XU,Liqun YANG,Yuming SUN,Weifeng YU

2009-01-01

Abstract:Objective To investigate the effect of N-acetylcysteine (NAC) on CCI-induced neuropathic pain and neuron apoptosis in rats. Methods Sixty Sprague-Dawley rats were randomly divided into Sham group,NAC group and normal saline (NS) group. Neuropathic pain was produced in the latter 2 groups by ligation of right sciatic nerve according to the technique described by Bennett and Xie. Rats in NAC group were given NAC (300 mg/kg per day) and those in NC group were given the same dose of normal saline. Changes of serum superoxide dismutase (SOD) expression were measured in all groups. Caspase-3 expression was detected by immunohistochemistry and apoptosis of neurons was detected by TUNEL. The pain thresholds to thermal stimulation of the right paw were compared between NAC group and NS group.Results The pain thresholds in Sham group were significantly higher than those of NAC group and NS group at 1,3,7,and10 days after operation (all P0.05),and those of group NAC were significantly higher than those of group NS (all P0.05). On the 7th day after operation,the spinal SOD level in NAC and NS groups reached the lowest ([20.099±5.265] and [21.171±7.616] U/mg,respectively),which were significantly lower than that of the Sham group ([35.088±3.616] U/mg,both P0.05); the spinal SOD levels were not significantly different at other time points among the 3 groups (all P0.05). Spinal caspase-3 expression was low in the Sham group; the expression in the Ⅰ,Ⅱ spinal layers in rats of NAC and NS group was obviously increased,but that of the NAC group was less than that of the NS group. The neuron apoptosis in NAC group was significantly higher than that of the Sham group (P0.05),but was lower than that of the NS group (P0.05).Conclusion It is concluded that NAC can inhibit neural apoptosis in the spinal cord dorsal horn and alleviate thermal hyperalgesia induced by CCI,indicating that NAC may be a potential candidate for treatment of neuropathic pain.